Clinical Trial

Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is an intervention study to investigate the impact of a smart ankle-foot orthosis (AFO) on mobility outcomes in children with Cerebral Palsy. Participants will complete a three phase protocol including 6-weeks of at home training with the smart AFO. Participants will also have the option to participate in a randomized control trial to investigate the impact of 5-Azacitidine combined with the smart AFO to further effect mobility outcomes.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-02
Trial Details
NCT Number NCT07434492
Lead Sponsor Shirley Ryan AbilityLab
Conditions Cerebral Palsy
Enrollment 60 participants
Start Date 2026-05-28
Primary Completion 2030-08-31 (estimated)
Study Completion 2030-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-01